| For Practicing Oncologists |
  See all
 | Articles: Myeloproliferative Dz |
Current status of therapy for chronic myeloid leukemia: a review of drug development
Future Oncology, 06/12/08
Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative
British Journal of Haematology, 06/12/08
Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders
Leukemia, 06/11/08
 | | Sponsor |
Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
Journal of Clinical Oncology, 06/11/08
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
Leukemia, 06/10/08
Chronic myeloid leukemia following the treatment of rectal adenocarcinoma
Medical Oncology, 06/10/08
Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease
Blood, 06/09/08
Concurrent Megakaryocytic and Erythroid Chronic Myelogenous Leukemia Blast Crisis
Archives of Pathology and Laboratory Medicine, 06/09/08
Involvement of Hepcidin in the Anemia of Multiple Myeloma
Clinical Cancer Research, 06/05/08
Antitumour and antiangiogenic effects of Aplidin in the 5TMM syngeneic models of multiple myeloma
British Journal of Cancer, 06/05/08
|
|
Receive daily email updates on Myeloproliferative Dz
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
150 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
|
| Sponsor |
|
